# Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clinical-and-molecular-characteristics-of-her2-low-positive-breast-cancer-pooled/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Carsten Denkert,Fenja Seither,Andreas Schneeweiß,Theresa Link,Jens‐Uwe Blohmer,Marianne Just,Pauline Wimberger,A Forberger,Hans Tesch,Christian Jackisch,Sabine Schmatloch,Mattea Reinisch,Erich Solomayer,Wolfgang Schmitt,Claus Hanusch,Peter A. Fasching,Kristina Lübbe,Christine Solbach,Jens Huober,Kerstin Rhiem,Frederik Marmé,Toralf Reimer,Marcus Schmidt,Bruno V. Sinn,Wolfgang Janni,Elmar Stickeler,Laura L. Michel,Oliver Stötzer,Eric Hahnen,Jenny Furlanetto,Sabine Seiler,Valentina Nekljudova,Michael Untch,Sibylle Loibl |
| Citations | 571 |
| DOI | 10.1016/s1470-2045(21)00301-6 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3179156059 |
| PMID | 34252375 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Jens‐Uwe Blohmer](https://scholariq.org/researchers/jens-uwe-blohmer/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.